Compared with chemotherapy alone, treatment with a combination of chemotherapy and the investigational drug iniparib improved overall survival by more than four months among women with metastatic, triple negative breast cancer. The results of this Phase II clinical trial were …
Tag: breast cancer
Aromatase Inhibitors May Increase Risk of Heart Disease
Aromatase inhibitors—hormonal therapy drugs commonly used in the treatment of postmenopausal breast cancer—may increase the risk of heart disease. These results were presented at the 2010 San Antonio Breast Cancer Symposium. Tamoxifen and aromatase inhibitors are hormonal therapy drugs that …
